PANTANI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 597
EU - Europa 247
AS - Asia 96
AF - Africa 4
OC - Oceania 2
SA - Sud America 2
Totale 948
Nazione #
US - Stati Uniti d'America 586
IT - Italia 61
FR - Francia 55
CN - Cina 41
GB - Regno Unito 26
DE - Germania 25
IE - Irlanda 23
IN - India 18
JP - Giappone 13
CA - Canada 11
NL - Olanda 9
BG - Bulgaria 8
SE - Svezia 7
UA - Ucraina 7
ES - Italia 5
HK - Hong Kong 5
VN - Vietnam 5
CZ - Repubblica Ceca 4
FI - Finlandia 3
IL - Israele 3
KR - Corea 3
NO - Norvegia 3
RU - Federazione Russa 3
TW - Taiwan 3
ZA - Sudafrica 3
AU - Australia 2
BE - Belgio 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
HR - Croazia 1
IS - Islanda 1
JO - Giordania 1
LU - Lussemburgo 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
Totale 948
Città #
Ashburn 120
Houston 38
Santa Cruz 34
Fairfield 33
Ann Arbor 25
Seattle 25
Buffalo 22
Dublin 20
Bologna 16
Chicago 14
Wilmington 14
San Diego 12
Boardman 10
Milan 10
Woodbridge 10
Cambridge 9
Chandler 9
New York 9
Paris 8
Sofia 8
Bremen 7
Fabriano 7
Bengaluru 6
Guangzhou 6
Shanghai 6
Bischheim 5
Madison 5
Mountain View 5
San Francisco 5
Southend 5
Wuhan 5
Beijing 4
Hamburg 4
Los Angeles 4
Ottawa 4
Stockholm 4
Amsterdam 3
Brookline 3
Cardiff 3
Columbus 3
Dong Ket 3
Frankfurt am Main 3
Milpitas 3
Muizenberg 3
Oslo 3
Provo 3
Austin 2
Bellaria-Igea Marina 2
Boston 2
Boulder 2
Brussels 2
Burnaby 2
Charlottesville 2
Clearwater 2
Council Bluffs 2
Florissant 2
Genoa 2
Hangzhou 2
Helsinki 2
Lake Forest 2
London 2
McHenry 2
New Orleans 2
Plymouth 2
Ramat HaSharon 2
Rimini 2
Seoul 2
Toronto 2
Umeda 2
Aarhus 1
Ahmedabad 1
Athens 1
Atlanta 1
Auburn 1
Ballyclare 1
Baltimore 1
Bari 1
Bethesda 1
Bonn 1
Brno 1
Büdelsdorf 1
Calgary 1
Catanzaro 1
Cedar Knolls 1
Central District 1
Charlotte 1
Clinton 1
Conversano 1
Crugers 1
Dehradun 1
Des Moines 1
Downers Grove 1
Enfield 1
Evanston 1
Florence 1
Fort Collins 1
Fuzhou 1
Gennep 1
Gubbio 1
Gurgaon 1
Totale 635
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease, file e1dcb336-c0cf-7715-e053-1705fe0a6cc9 288
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma, file e1dcb336-5551-7715-e053-1705fe0a6cc9 185
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma., file e1dcb332-a917-7715-e053-1705fe0a6cc9 92
Treatment optimization for Multiple Myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in an in vitro and ex-vivo model, file e1dcb335-7a0c-7715-e053-1705fe0a6cc9 65
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents, file e1dcb32f-2aa3-7715-e053-1705fe0a6cc9 63
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma, file e1dcb339-d8d7-7715-e053-1705fe0a6cc9 63
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma, file e1dcb335-52f0-7715-e053-1705fe0a6cc9 60
Early Light Chains Removal and Albumin Levels with a Double Filter-Based Extracorporeal Treatment for Acute Myeloma Kidney, file 41b7d9a3-e5da-4c86-aa16-3bcdac369bac 28
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients, file c98b8a6c-52ea-40eb-9081-4d2f4d2811aa 23
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma, file e1dcb339-aac2-7715-e053-1705fe0a6cc9 20
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases, file 11e3ddaf-42a3-45f5-9568-708677b17117 15
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma, file e1dcb335-52f1-7715-e053-1705fe0a6cc9 15
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma, file eace3be2-8518-47e0-be44-569952f6bb37 14
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial, file 0415def4-dbd9-4035-8578-4dfc2fcf955c 13
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma., file e1dcb32c-ea06-7715-e053-1705fe0a6cc9 7
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial, file da8ae0f8-61d3-4f27-8d0e-414c5b49a5ff 6
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials, file 1071f612-5177-43ab-a363-861587d0ab2c 5
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials, file d683cc65-edf1-4f8c-9350-ac021cbdfd06 4
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma, file 30987cd1-61c8-42b7-8afd-bd6ca7056083 3
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma, file 7f0eb466-1a69-420a-829b-c3a81e43fa5b 1
Totale 970
Categoria #
all - tutte 2.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202041 0 0 0 2 4 4 7 4 5 3 5 7
2020/202185 3 10 2 3 1 4 4 14 12 11 12 9
2021/2022275 19 14 15 49 33 10 18 10 9 25 56 17
2022/2023255 9 24 40 38 16 14 15 12 25 11 38 13
2023/2024313 3 15 17 39 25 40 37 103 19 12 3 0
Totale 970